Evidence map›Paper›PMID 35072147›Full record

ArticleLancet regional health. Americas2022

Impact of the COVID-19 pandemic on the diagnosis of leprosy in Brazil: An ecological and population-based study.

Wandklebson Silva da Paz, Mariana do Rosário Souza, Débora Dos Santos Tavares, Amélia Ribeiro de Jesus, Allan Dantas Dos Santos, Rodrigo Feliciano do Carmo, Carlos Dornels Freire de Souza, Márcio Bezerra-Santos

Open access · goldAbstract read
In one paragraph

Article in Lancet regional health. Americas, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Self-healing in leprosy: A systematic review.PLoS neglected tropical diseases · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Brazil accounts for nearly 90% of the leprosy cases in the Americas.Revista da Sociedade Brasileira de Medicina Tropical · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Wandklebson Silva da PazTropical Medicine Graduate Program, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil.
Mariana do Rosário SouzaParasitic Biology Graduate Program, Universidade Federal de Sergipe, São Cristóvão, Sergipe, Brazil.
Débora Dos Santos TavaresDepartment of Health Education, Universidade Federal de Sergipe, Lagarto, Sergipe, Brasil.
Amélia Ribeiro de JesusHealth Science Graduate Program, Universidade Federal de Sergipe, São Cristóvão, Sergipe, Brazil.
Allan Dantas Dos SantosDepartment of Nursing, Universidade Federal de Sergipe, Lagarto, Sergipe, Brasil.
Rodrigo Feliciano do CarmoCollege of Pharmaceutical Sciences, Federal University of Vale do São Francisco (UNIVASF), Petrolina, PE, Brazil.
Carlos Dornels Freire de SouzaDepartment of Medicine, Universidade Federal de Alagoas, Arapiraca, Alagoas, Brazil.
Márcio Bezerra-SantosParasitic Biology Graduate Program, Universidade Federal de Sergipe, São Cristóvão, Sergipe, Brazil.
Universidade Federal de Sergipe · BRUniversidade Federal de Alagoas · BRUniversidade Federal do Vale do São Francisco · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe pandemic caused by COVID-19 has seriously affected global health, resulting in the suspension of many regular health services, making the diagnosis of other infections difficult. Therefore, this study aimed to assess the impact of the COVID-19 pandemic on the diagnosis of leprosy in Brazil during the year 2020.

methodsWe evaluated the monthly incidence of leprosy and calculated the percentage change to verify whether there was an increase or decrease in the number of leprosy cases in 2020, considering the monthly average of cases over the previous 5 years. We used interrupted time series analysis to assess the trend in the diagnosis of leprosy before and after the start of COVID-19 in Brazil and prepared spatial distribution maps, considering the percentage variation in each state.

findingsWe verified a reduction of 41.4% of leprosy cases in Brazil in 2020. Likewise, there was a reduction of leprosy notifications in children under 15 years-old (-56.82%). Conversely, the diagnosis of multibacillary leprosy increased (8.1%). There was a decreasing trend in the leprosy incidence in the general population between 2015 and 2020 in Brazil. Spatial distribution maps depicted a reduction of up to 100% in new cases of leprosy in some states.

interpretationAlong with COVID-19 spread there was a reduction in leprosy diagnosis in the general population and children under 15 years-old, and also an increase in multibacillary cases diagnosed, signalling a serious impact of the pandemic on leprosy control strategies in Brazil.

fundingThis research received no specific grants.

Indexed as

BrazilHealth ServicesLeprosyPandemicSARS-CoV-2

Identifiers

PMID35072147
PMCPMC8759948
OpenAlexW4205528289

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.